These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29372566)

  • 1. Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity.
    Choksi Y; Slaughter JC; Sharda R; Higginbotham T; Lal P; Vaezi MF
    Aliment Pharmacol Ther; 2018 Apr; 47(7):958-965. PubMed ID: 29372566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
    Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M; Conigliaro R; Mirante VG; Melotti G
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
    Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
    Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
    de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
    Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
    Spechler SJ
    Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
    Martinez SD; Malagon IB; Garewal HS; Cui H; Fass R
    Aliment Pharmacol Ther; 2003 Feb; 17(4):537-45. PubMed ID: 12622762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.
    Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E
    J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
    Savarino E; Zentilin P; Mastracci L; Dulbecco P; Marabotto E; Gemignani L; Bruzzone L; de Bortoli N; Frigo AC; Fiocca R; Savarino V
    J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom association latency during ambulatory reflux monitoring: a review of 1445 symptoms.
    Abdul-Hussein M; Castell D
    Dis Esophagus; 2017 Oct; 30(10):1-6. PubMed ID: 28859384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
    Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
    Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnosis of reflux hypersensitivity.
    Voulgaris T; Hoshino S; Sifrim D; Yazaki E
    Neurogastroenterol Motil; 2023 Dec; 35(12):e14680. PubMed ID: 37731341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
    Tack J; Fass R
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.